BIOMAT Database Logo BIOMAT Database Logo

Prophylaxis with urokinase in pediatric oncology patients with central venous catheters. 2002

Maria Kalmanti, and John Germanakis, and Eftichia Stiakaki, and Cathrin Syfridaki, and Athanasia Christidou, and Dimitris Tsetis, and Panagiotis Vardas, and George Charisis
Department of Pediatric Hematology/Oncology, University Hospital of Heraklion, Crete, Greece. pedhem@med.uoc.gr

This study evaluated the effects of urokinase in the prevention of central venous catheter (CVC)-related complications in children with malignancy. Fifteen patients with 16 CVCs (study group A) received an intraluminal application of urokinase (10,000 IU in each catheter lumen for 4 h) once a week. They were monitored prospectively with quantitative blood cultures and ultrasonography (color Doppler ultrasound of the great veins and echocardiography). The rate of complications was compared with that of 15 children with 19 CVCs without thromboprophylaxis, treated the previous significantly lower incidence of CVC dysfunction year (control group B). The authors found a wer incidence of CVC dysfunction (3/16 versus 13/19), no major thrombosis, fewer CVC-related bacteremias (2/16 versus 8/19), and a higher salvage of CVCs (1/16 versus 5/19 CVC removals due to persistent bacteremia) in the thromboprophylaxis group. Asymptomatic thrombosis rate was also lower (7/16 cases in group A versus 9/11 in group B when sonography was performed). No hemorrhagic complications were noted. Thromboprophylaxis with urokinase seems a safe and effective measure for reducing the rate of CVC-related complications.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002405 Catheterization, Central Venous Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein. Central Venous Catheterization,Venous Catheterization, Central,Catheterization, Central,Central Catheterization,Catheterizations, Central,Catheterizations, Central Venous,Central Catheterizations,Central Venous Catheterizations,Venous Catheterizations, Central
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

Maria Kalmanti, and John Germanakis, and Eftichia Stiakaki, and Cathrin Syfridaki, and Athanasia Christidou, and Dimitris Tsetis, and Panagiotis Vardas, and George Charisis
Urokinase administration in pediatric patients with occluded central venous catheters.
January 1990, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society,
Maria Kalmanti, and John Germanakis, and Eftichia Stiakaki, and Cathrin Syfridaki, and Athanasia Christidou, and Dimitris Tsetis, and Panagiotis Vardas, and George Charisis
Dose-ranging trial with a recombinant urokinase (urokinase alfa) for occluded central venous catheters in oncology patients.
June 2004, Journal of vascular and interventional radiology : JVIR,
Maria Kalmanti, and John Germanakis, and Eftichia Stiakaki, and Cathrin Syfridaki, and Athanasia Christidou, and Dimitris Tsetis, and Panagiotis Vardas, and George Charisis
[Long-term experiences with central venous catheters in pediatric oncology].
January 1990, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
Maria Kalmanti, and John Germanakis, and Eftichia Stiakaki, and Cathrin Syfridaki, and Athanasia Christidou, and Dimitris Tsetis, and Panagiotis Vardas, and George Charisis
Single- vs double-lumen central venous catheters in pediatric oncology patients.
August 1988, American journal of diseases of children (1960),
Maria Kalmanti, and John Germanakis, and Eftichia Stiakaki, and Cathrin Syfridaki, and Athanasia Christidou, and Dimitris Tsetis, and Panagiotis Vardas, and George Charisis
Bacteremia in nonneutropenic pediatric oncology patients with central venous catheters in the ED.
January 2017, The American journal of emergency medicine,
Maria Kalmanti, and John Germanakis, and Eftichia Stiakaki, and Cathrin Syfridaki, and Athanasia Christidou, and Dimitris Tsetis, and Panagiotis Vardas, and George Charisis
[Central venous catheters in pediatric patients].
September 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
Maria Kalmanti, and John Germanakis, and Eftichia Stiakaki, and Cathrin Syfridaki, and Athanasia Christidou, and Dimitris Tsetis, and Panagiotis Vardas, and George Charisis
[Venous approach in pediatric oncology. Arteriovenous fistulas or central venous catheters?].
October 1984, Annales de pediatrie,
Maria Kalmanti, and John Germanakis, and Eftichia Stiakaki, and Cathrin Syfridaki, and Athanasia Christidou, and Dimitris Tsetis, and Panagiotis Vardas, and George Charisis
Prevalence of Symptomatic and Asymptomatic Thrombosis in Pediatric Oncology Patients With Tunneled Central Venous Catheters.
August 2016, Pediatric blood & cancer,
Maria Kalmanti, and John Germanakis, and Eftichia Stiakaki, and Cathrin Syfridaki, and Athanasia Christidou, and Dimitris Tsetis, and Panagiotis Vardas, and George Charisis
Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients.
October 2004, The Pediatric infectious disease journal,
Maria Kalmanti, and John Germanakis, and Eftichia Stiakaki, and Cathrin Syfridaki, and Athanasia Christidou, and Dimitris Tsetis, and Panagiotis Vardas, and George Charisis
[Central venous catheters with subcutaneous ports for long-term chemotherapy in pediatric oncology].
January 1992, Acta haematologica Polonica,
Copied contents to your clipboard!